Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:interferon_gamma
gptkb:interferon_alpha-2b |
| gptkbp:administeredBy |
gptkb:physician
|
| gptkbp:approvedBy |
gptkb:Cuba
2016 |
| gptkbp:ATCCode |
gptkb:L03AB
|
| gptkbp:countryOfOrigin |
gptkb:Cuba
|
| gptkbp:developedBy |
Center for Genetic Engineering and Biotechnology (CIGB)
|
| https://www.w3.org/2000/01/rdf-schema#label |
Heberferon
|
| gptkbp:indication |
basal cell carcinoma
non-melanoma skin cancer |
| gptkbp:mechanismOfAction |
immunomodulation
antiproliferative effect antiviral effect |
| gptkbp:routeOfAdministration |
injection
|
| gptkbp:sideEffect |
fatigue
injection site reaction flu-like symptoms |
| gptkbp:usedFor |
treatment of basal cell carcinoma
|
| gptkbp:bfsParent |
gptkb:Center_for_Genetic_Engineering_and_Biotechnology
|
| gptkbp:bfsLayer |
7
|